Results 211 to 220 of about 2,529,459 (356)

A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. [PDF]

, 1989
Y Morishita, Hui Sao, J A Hansen, Paul J. Martin   +3 more
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity. [PDF]

Clin Cosmet Investig Dermatol
Namasondhi A, Rutnin S, Jerasutus S, Boonsakan P, Triyangkulsri K.   +4 more
europepmc   +1 more source

The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype. [PDF]

, 1985
Neal W. Roehm, Amy Carbone, E Kushnir, Benjamin A. Taylor, Roy Riblet, Philippa Marrack, J W Kappler   +6 more
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Distinct T Cell Subset Profiles and T-Cell Receptor Signatures in Metabolically Unhealthy Obesity. [PDF]

Int J Mol Sci
Chung Y, Chang JY, Soedono S, Julietta V, Joo EJ, Kwon SH, Choi SI, Kim YJ, Cho KW.   +8 more
europepmc   +1 more source

Functional isotypes are not encoded by the constant region genes of the beta subunit of the T cell receptor for antigen/major histocompatibility complex. [PDF]

, 1984
H D Royer, Armand Bensussan, Oreste Acuto, Ellis L. Reinherz   +3 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

T cell receptor activation contributes to brain damage after intracerebral hemorrhage in mice. [PDF]

J Neuroinflammation
Xiu Y, Wang Y, Wang N, Liu N, Jiang Y, Shi M, Zhou D, Sein TY, Kilgore MD, Katakam PVG, Liu Q, Jin WN, Shi FD, Wang X, Dumont AS.   +14 more
europepmc   +1 more source

Functional analysis of the interaction of the antigen-specific T cell receptor with its ligands. [PDF]

, 1986
Jonathan D. Ashwell, Barbara S. Fox, R H Schwartz   +2 more
openalex   +1 more source